The extraordinary breakthrough in how ‘killer’ CD8 + T cells – the body’s ‘army of hitmen’ tasked with taking out new viruses – retain memories of virus strains they encounter was published in the prestigious Nature Communications journal this week (May 13).
University of Melbourne’s Associate Professor Katherine Kedzierska explained how the Australia-Sino collaboration began during the first outbreak of the avian-derived H7N9 virus in China in 2013.
That contagion saw 99% of people infected hospitalised, with a 30% mortality rate. Patient zero was an elderly man who caught the virus from a chicken his wife asked him to buy at the local live bird market.
“We’d never seen anything like H7N9,” Associate Professor Kedzierska said. “The virus was infecting more people rapidly and nobody had immunity. Thankfully, we did manage to contain the virus but we knew we had come face-to-face with a potential pandemic that could kill millions of people around the world if the virus became able to spread between humans,” she said.
“After collecting samples from infected patients we found that people who couldn’t make these T cell flu assassins were dying. These findings lead to the potential of moving from vaccines for specific influenza strains toward developing a protection, which is based on T-cells,” she said.
“From the 30% mortality rate in China we knew the clock was ticking on the situation. Had the contagion spread broken out globally, we’re talking about a history-altering event on the Spanish Flu scale. As it turns out, boosting the T cell adaptive memory capacity is our way in,” Associate Prof Kedzierska said.
“Our extraordinary breakthrough could lead to the development of a vaccine component that can protect against all new influenza viruses, with the potential for future development of a one-off universal flu vaccine shot,” she said. “This work will also help clinicians to make early predictions of how well a patient’s immune system will respond to viruses so they can manage early interventions such as artificial ventilation more effectively, particularly in cases where the patient is at risk of dying.”
The Latest on: Flu vaccine
via Google News
The Latest on: Flu vaccine
- Influenza-like activity soars again during historic flu season amid escalating pandemicon March 27, 2020 at 1:26 pm
Visits to health care providers for flu-like illnesses increased for the third straight week, jumping 13.2 percent from last week. The Centers for Disease Control and Prevention (CDC) notes the ...
- 4 Holland America cruise passengers die on ship; 138 sick with 'influenza-like' symptomson March 27, 2020 at 11:10 am
Our thoughts and prayers are with their families and we are doing everything we can to support them during this difficult time." ...
- Crew members evacuated from cruise ships in Florida after experiencing 'influenza-like symptoms'on March 27, 2020 at 6:38 am
The U.S. Coast Guard confirmed on Thursday that it had helped evacuate 13 crew members from two Costa Cruises ships following reports that dozens onboard were feeling ill.
- What the author of 'The Great Influenza: The Story of the Deadliest Pandemic in History' can teach us about coronaviruson March 27, 2020 at 4:05 am
I've been reading a great book about a horrific pandemic that gripped the world more than a century ago, John M. Barry's "The Great Influenza: The Story of the Deadliest ...
- DHEC: Influenza activity decreased across S.C. last weekon March 26, 2020 at 8:29 pm
The South Carolina Department of Health and Environmental Control says there was a decrease in influenza activity this past week in South Carolina. According to the agency, there have been 164 cases ...
- What the 1918 influenza pandemic can teach us about coronaviruson March 25, 2020 at 10:44 pm
John Barry who has written extensively about the 1918 influenza pandemic joins to reveal what lessons it could teach us about the coronavirus.
- This 106-year-old family business survived the Spanish influenza – but its fourth-generation owner says they've never seen anything like thison March 25, 2020 at 9:53 pm
Russ & Daughters, a fixture in New York City since 1914, has weathered the Spanish flu, wars, depressions, recessions, and hurricanes. But for the first time in the business's history, they've had to ...
- Influenza Therapeutics Market provides an in-depth insight of Sales and Trends Forecast to 2026on March 25, 2020 at 9:31 pm
Influenza is an infection that is characterized by sudden onset of fever, headache, sore throat, non-productive cough, and rhinitis. There are four types of influenza virus such as A, B, C, and D.
- Novavax Rallies as Influenza Vaccine Meets All Goals in Studyon March 25, 2020 at 12:52 pm
NanoFlu, the influenza vaccine candidate for adults aged 65 years and older, meets all the primary and secondary endpoints in late-stage study. Shares rise.
- Can Novavax’s Surge Continue Following Positive Data for Flu Vaccine?on March 25, 2020 at 9:31 am
If you think the broader market’s extreme pendulum swings are the definition of volatility, you should have a conversation with long-term investors of vaccine specialist Novavax (NVAX). To quickly ...
via Bing News